These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia. Chokshi N; Blumenschein SD; Ahmad Z; Garg A J Clin Lipidol; 2014; 8(3):287-95. PubMed ID: 24793350 [TBL] [Abstract][Full Text] [Related]
9. Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene. Berge KE; Retterstøl K; Romeo S; Pirazzi C; Leren TP Atherosclerosis; 2014 May; 234(1):30-3. PubMed ID: 24589565 [TBL] [Abstract][Full Text] [Related]
10. Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650). Wang J; Hegele RA Lipids Health Dis; 2007 Sep; 6():23. PubMed ID: 17883852 [TBL] [Abstract][Full Text] [Related]
11. Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report. Lin MH; Tian XH; Hao XL; Fei H; Yin JL; Yan DD; Li T BMC Pregnancy Childbirth; 2020 May; 20(1):272. PubMed ID: 32375710 [TBL] [Abstract][Full Text] [Related]
12. Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis. Ariza MJ; Martínez-Hernández PL; Ibarretxe D; Rabacchi C; Rioja J; Grande-Aragón C; Plana N; Tarugi P; Olivecrona G; Calandra S; Valdivielso P J Clin Lipidol; 2016; 10(1):92-100.e1. PubMed ID: 26892125 [TBL] [Abstract][Full Text] [Related]
13. GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia. Charrière S; Peretti N; Bernard S; Di Filippo M; Sassolas A; Merlin M; Delay M; Debard C; Lefai E; Lachaux A; Moulin P; Marçais C J Clin Endocrinol Metab; 2011 Oct; 96(10):E1675-9. PubMed ID: 21816778 [TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia. Caddeo A; Mancina RM; Pirazzi C; Russo C; Sasidharan K; Sandstedt J; Maurotti S; Montalcini T; Pujia A; Leren TP; Romeo S; Pingitore P Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):158-164. PubMed ID: 29288010 [TBL] [Abstract][Full Text] [Related]
15. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects. Franssen R; Young SG; Peelman F; Hertecant J; Sierts JA; Schimmel AW; Bensadoun A; Kastelein JJ; Fong LG; Dallinga-Thie GM; Beigneux AP Circ Cardiovasc Genet; 2010 Apr; 3(2):169-78. PubMed ID: 20124439 [TBL] [Abstract][Full Text] [Related]
16. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia. Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148 [TBL] [Abstract][Full Text] [Related]
18. Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene. Kim KY; Heo YJ; Ko JM; Lee YA; Shin CH; Ki CS; Lee YJ BMC Endocr Disord; 2024 Apr; 24(1):47. PubMed ID: 38622573 [TBL] [Abstract][Full Text] [Related]
19. A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase. Kristensen KK; Midtgaard SR; Mysling S; Kovrov O; Hansen LB; Skar-Gislinge N; Beigneux AP; Kragelund BB; Olivecrona G; Young SG; Jørgensen TJD; Fong LG; Ploug M Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6020-E6029. PubMed ID: 29899144 [TBL] [Abstract][Full Text] [Related]
20. A novel GPIHBP1 mutation related to familial chylomicronemia syndrome: A series of cases. Lima JG; Helena C Nobrega L; Moura Bandeira FT; Pires Sousa AG; Medeiros de Araujo Macedo TB; Cavalcante Nogueira AC; Fernandes de Oliveira Filho A; Alves RJ; Costa Gurgel Castelo MH; Silva Coelho FM; Maia RE; Lima DN; Timoteo ARS; de Melo Campos JTA Atherosclerosis; 2021 Apr; 322():31-38. PubMed ID: 33706081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]